Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+3.05%)
As of: Oct 2, 2026 · 10:47 AM EDT

Rani Therapeutics Holdings (RANI) Receivables - Accured (2022 - 2023)

Updated

Rani Therapeutics Holdings (RANI) reported Receivables - Accured of $200,000 for Q4 2023, unchanged from $200,000 a year earlier and unchanged from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Receivables - Accured (2022 - 2023) Analysis & Trends

Dating back to Q4 2022, Rani Therapeutics Holdings' Receivables - Accured record includes 5 quarters.

  • By year, Receivables - Accured came in at $200,000 in FY2022.
  • Per Business Quant data, the three quarters before Q4 2023 came in at $200,000 (Q3 2023), $200,000 (Q2 2023) and $100,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 200,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 200,000.00
API Access

Rani Therapeutics Holdings Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=RANI&period=max&api_key=YOUR_API_KEY